TY - JOUR KW - castration KW - boar-taint KW - GnRF KW - vaccination AU - A Albrecht AU - E große Beilage AU - M Henning AU - T  Bekendorf AU - J Krieter AB - The present study assessed the effects of using Improvac TM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males ... BT - Berliner und Münchener Tierärztliche Wochenschrift C1 - {"oldId":70732,"title":"Growth performance and carcass characteristics of ImprovacTM-treated male pigs compared with barrows","teaserText":"The present study assessed the effects of using Improvac TM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males ...","content":"

Summary<\/span>
\r\nThe present study assessed the effects of using ImprovacTM<\/span> (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males was estimated in order to demonstrate differences in growing patterns in these two treatment groups. The study was carried out in two identical batches. Pigs within batches (n = 5) were allocated to two different treatment groups: immunisation (IM) versus surgical castration (CM). Within treatment groups pigs were randomly assigned to two different diets (low- and high-lysine diet) in order to examine interactions of growth performance and castration technique. Vac- cination was performed on the day of entry to the fattening unit and four to six weeks prior to slaughter. At the second vaccination IM-pigs showed significantly lower body weights than the control group (p high) tended to be higher than IMF in immunised pigs fed low-lysine diets (IMlow<\/span>). This effect was not seen in surgical castrates in either batch. Immunisation against GnRH offers a good approach to produce taint-free pork while ensuring boar-like growth for a large part of the fattening period.\r\n

\r\n\r\nKeywords:<\/span>
\r\ncastration, boar-taint, GnRF, vaccination\r\n\r\n\r\n\r\n\r\n


\r\n\r\nZusammenfassung<\/span>
\r\nDie vorliegende Studie hatte zum Ziel, die Auswirkung der Impfung mit ImprovacTM <\/span>(Pfizer Animal Health, D) auf Wachstumsleistung und Fleischbeschaffenheit bei m\u00e4nnlichen Mastschweinen zu erfassen. Zus\u00e4tzlich wurden mittels der Wachstumsfunktion die durchschnittlichen t\u00e4glichen Zunahmen von geimpften und chirurgisch kastrierten m\u00e4nnlichen Mastschweinen gesch\u00e4tzt und Unter- schiede im Wachstumsverlauf der zwei Versuchsgruppen verglichen. Die Datenerfassung erfolgte in zwei aufeinanderfolgenden Mastdurchg\u00e4ngen. Alle Tiere je Durchgang (n = 5) wurden zuf\u00e4llig in die folgenden zwei Versuchs- gruppen aufgeteilt: Impfung (IM) versus chirurgische Kastration (CM). Innerhalb der Versuchsgruppen erfolgte eine Verteilung der Tiere auf zwei unterschiedliche Futtergruppen (niedriger und hoher Lysingehalt im Futter), um Interaktionen von Kastrationstechnik und Wachstumsleistung zu untersuchen. Die Impfung erfolgte am Tag der Einstallung zur Mast und vier bis sechs Wochen vor der Schlachtung. Zum Zeitpunkt der zweiten Impfung zeigten IM-Schweine in beiden Durchg\u00e4ngen signifikant niedrigere Korpergewichte als die Kontrollgruppe\r\n(p
\r\nSchl\u00fcsselw\u00f6rter:<\/span>
\r\nKastration, Ebergeruch, GnRF, Impfung\r\n\r\n\r\n\r\n<\/p>","categories":["Tier\u00e4rztliche Wochenschrift","Abostufe BMTW","Fachartikel"],"fromDate":"Nov 12, 2012 12:00:00 AM","toDate":"Dec 31, 2050 12:00:00 AM","oldUrls":["http:\/\/vetline.de\/castration-boar-taint-gnrf-vaccination\/150\/3130\/70732"],"doiLanguage":"englisch","doiProductFormat":"Online","doiPublisher":"Schl\u00fctersche Verlagsgesellschaft mbH & Co. KG","doiSerialWorkTitle":"Berl. M\u00fcnch. Tier\u00e4rztl. Wschr.","doiDocumentUri":"http:\/\/www.vetline.de\/castration-boar-taint-gnrf-vaccination\/150\/3130\/70732","doiSource":"Berl. M\u00fcnch. Tier\u00e4rztl. Wschr. 125: 11-12, 456-462 (2012)","doiissn":"0005-9366","doiNr":"10.2376\/0005-9366-125-456","doiFirstPage":"456","doiLastPage":"462","doiTransmitted":true,"doiAuthor":"Albrecht A, Beilage E, Henning M, Bekendorf T\ufeff, Krieter J","pdf":{"path":"http:\/\/data\/bmtw_2012_11_0456.pdf","title":"bmtw_2012_11_0456.pdf","description":"Growth performance and carcass characteristics of ImprovacTM-treated male pigs compared with barrows

"},"authors":[{"firstName":"A","middleName":"","lastName":"Albrecht"},{"firstName":"E","middleName":"","lastName":"Beilage"},{"firstName":"M","middleName":"","lastName":"Henning"},{"firstName":"T","middleName":"\ufeff","lastName":"Bekendorf"},{"firstName":"J","middleName":"","lastName":"Krieter"}],"contentOptimised":"

Summary<\/strong>
\nThe present study assessed the effects of using ImprovacTM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males was estimated in order to demonstrate differences in growing patterns in these two treatment groups. The study was carried out in two identical batches. Pigs within batches (n = 5) were allocated to two different treatment groups: immunisation (IM) versus surgical castration (CM). Within treatment groups pigs were randomly assigned to two different diets (low- and high-lysine diet) in order to examine interactions of growth performance and castration technique. Vac- cination was performed on the day of entry to the fattening unit and four to six weeks prior to slaughter. At the second vaccination IM-pigs showed significantly lower body weights than the control group (p high) tended to be higher than IMF in immunised pigs fed low-lysine diets (IMlow). This effect was not seen in surgical castrates in either batch. Immunisation against GnRH offers a good approach to produce taint-free pork while ensuring boar-like growth for a large part of the fattening period.\n

\n\nKeywords:<\/strong>
\ncastration, boar-taint, GnRF, vaccination\n\n\n\n\n


\n\nZusammenfassung<\/strong>
\nDie vorliegende Studie hatte zum Ziel, die Auswirkung der Impfung mit ImprovacTM (Pfizer Animal Health, D) auf Wachstumsleistung und Fleischbeschaffenheit bei m\u00e4nnlichen Mastschweinen zu erfassen. Zus\u00e4tzlich wurden mittels der Wachstumsfunktion die durchschnittlichen t\u00e4glichen Zunahmen von geimpften und chirurgisch kastrierten m\u00e4nnlichen Mastschweinen gesch\u00e4tzt und Unter- schiede im Wachstumsverlauf der zwei Versuchsgruppen verglichen. Die Datenerfassung erfolgte in zwei aufeinanderfolgenden Mastdurchg\u00e4ngen. Alle Tiere je Durchgang (n = 5) wurden zuf\u00e4llig in die folgenden zwei Versuchs- gruppen aufgeteilt: Impfung (IM) versus chirurgische Kastration (CM). Innerhalb der Versuchsgruppen erfolgte eine Verteilung der Tiere auf zwei unterschiedliche Futtergruppen (niedriger und hoher Lysingehalt im Futter), um Interaktionen von Kastrationstechnik und Wachstumsleistung zu untersuchen. Die Impfung erfolgte am Tag der Einstallung zur Mast und vier bis sechs Wochen vor der Schlachtung. Zum Zeitpunkt der zweiten Impfung zeigten IM-Schweine in beiden Durchg\u00e4ngen signifikant niedrigere Korpergewichte als die Kontrollgruppe\n(p
\nSchl\u00fcsselw\u00f6rter:<\/strong>
\nKastration, Ebergeruch, GnRF, Impfung\n\n\n\n<\/p>","primaryLanguage":"englisch","summary":"The present study assessed the effects of using ImprovacTM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males was estimated in order to demonstrate differences in growing patterns in these two treatment groups. The study was carried out in two identical batches. Pigs within batches (n = 5) were allocated to two different treatment groups: immunisation (IM) versus surgical castration (CM). Within treatment groups pigs were randomly assigned to two different diets (low- and high-lysine diet) in order to examine interactions of growth performance and castration technique. Vac- cination was performed on the day of entry to the fattening unit and four to six weeks prior to slaughter. At the second vaccination IM-pigs showed significantly lower body weights than the control group (p high) tended to be higher than IMF in immunised pigs fed low-lysine diets (IMlow). This effect was not seen in surgical castrates in either batch. Immunisation against GnRH offers a good approach to produce taint-free pork while ensuring boar-like growth for a large part of the fattening period.","keywords":["castration","boar-taint","GnRF","vaccination"],"zusammenfassung":"Die vorliegende Studie hatte zum Ziel, die Auswirkung der Impfung mit ImprovacTM (Pfizer Animal Health, D) auf Wachstumsleistung und Fleischbeschaffenheit bei m\u00e4nnlichen Mastschweinen zu erfassen. Zus\u00e4tzlich wurden mittels der Wachstumsfunktion die durchschnittlichen t\u00e4glichen Zunahmen von geimpften und chirurgisch kastrierten m\u00e4nnlichen Mastschweinen gesch\u00e4tzt und Unter- schiede im Wachstumsverlauf der zwei Versuchsgruppen verglichen. Die Datenerfassung erfolgte in zwei aufeinanderfolgenden Mastdurchg\u00e4ngen. Alle Tiere je Durchgang (n = 5) wurden zuf\u00e4llig in die folgenden zwei Versuchs- gruppen aufgeteilt: Impfung (IM) versus chirurgische Kastration (CM). Innerhalb der Versuchsgruppen erfolgte eine Verteilung der Tiere auf zwei unterschiedliche Futtergruppen (niedriger und hoher Lysingehalt im Futter), um Interaktionen von Kastrationstechnik und Wachstumsleistung zu untersuchen. Die Impfung erfolgte am Tag der Einstallung zur Mast und vier bis sechs Wochen vor der Schlachtung. Zum Zeitpunkt der zweiten Impfung zeigten IM-Schweine in beiden Durchg\u00e4ngen signifikant niedrigere Korpergewichte als die Kontrollgruppe\n(p","schluesselwoerter":["Kastration","Ebergeruch","GnRF","Impfung"],"translatedTitle":"","abstractE":"The present study assessed the effects of using Improvac TM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males ...","date":{"year":2012,"date":"11\/2012","accepted":"2012-11-12"},"volume":"125","openAccess":false,"journal":"Berliner und M\u00fcnchener Tier\u00e4rztliche Wochenschrift","titleImageId":944,"pages":"456-462","redirects":["castration-boar-taint-gnrf-vaccination\/150\/3130\/70732"],"tierartCategories":[],"artikelartCategories":["Tier\u00e4rztliche Wochenschrift","Abostufe BMTW","Fachartikel"]} CY - Hannover DA - 11/2012 DO - 10.2376/0005-9366-125-456 LA - English N2 - The present study assessed the effects of using Improvac TM (Pfizer Animal Health, Germany) on growth performance and meat characteristics in cross-bred male pigs. In addition average daily weight gain of immunised and surgically castrated males ... PB - Schlütersche Verlagsgesellschaft mbH & Co. KG PP - Hannover PY - 2012 SP - 456 EP - 462 T1 - Growth performance and carcass characteristics of ImprovacTM-treated male pigs compared with barrows T2 - Berliner und Münchener Tierärztliche Wochenschrift TI - Growth performance and carcass characteristics of ImprovacTM-treated male pigs compared with barrows VL - 125 SN - 0005-9366 ER -